肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

免疫球蛋白基因重排IGHV3-48是滤泡性淋巴瘤向侵袭性淋巴瘤组织学转化的预测标志物

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

原文发布日期:2019-06-17

DOI: 10.1038/s41408-019-0213-9

类型: Article

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

免疫球蛋白基因重排IGHV3-48是滤泡性淋巴瘤向侵袭性淋巴瘤组织学转化的预测标志物

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

原文发布日期:2019-06-17

DOI: 10.1038/s41408-019-0213-9

类型: Article

开放获取: 是

 

英文摘要:

Follicular lymphoma (FL) is a heterogeneous disease whose pathogenesis remains partially unknown. Around 20% of FL patients experience early progression or treatment-refractory disease and 2–3% of patients per year experience histological transformation (HT) into a more aggressive lymphoma (tFL). Here, we evaluate the immunoglobulin heavy chain variable (IGHV) gene usage and mutational status in 187 FL cases to assess its impact on clinical outcome and histological transformation. The IGHV gene repertoire was remarkably biased in FL. The IGHV4-34 (14%), IGHV3-23 (14%), IGHV3-48 (10%), IGHV3-30 (9%) and IGHV3-21 (7%) genes accounted for more than half of the whole cohort. IGHV3-48 was overrepresented in cases of tFL (19%) compared with non-transformed FL at 5 years (5%, P = 0.05). Patients with the IGHV3-48 gene were significantly more likely to have had HT after 10 years than those who used other genes (71% vs. 25%, P < 0.05), irrespective of the therapy they received. Moreover, IGHV3-30 was also overrepresented in cases of FL (9%) and tFL (13%) compared with diffuse large B-cell lymphoma in which it was nearly absent. In conclusion, our results indicate a role for antigen selection in the development of FL, while the use of IGHV3-48 could help predict histological transformation.
 

摘要翻译: 

滤泡性淋巴瘤(FL)是一种异质性疾病,其发病机制仍部分未知。大约20%的FL患者经历早期进展或治疗耐药疾病,每年有2-3%的患者经历组织学转化(HT)为更侵袭性的淋巴瘤(tFL)。在此,我们评估了187例FL病例的免疫球蛋白重链可变区(IGHV)基因使用和突变状态,以评估其对临床结果和组织学转化的影响。IGHV基因库在FL中明显偏向。IGHV4-34(14%)、IGHV3-23(14%)、IGHV3-48(10%)、IGHV3-30(9%)和IGHV3-21(7%)基因占整个队列的一半以上。与非转化FL在5年时(5%)相比,IGHV3-48在tFL病例中过度代表(19%,P=0.05)。使用IGHV3-48基因的患者在10年后发生HT的可能性显著高于使用其他基因的患者(71% vs. 25%,P<0.05),无论他们接受的治疗如何。此外,与弥漫大B细胞淋巴瘤(其中几乎不存在)相比,IGHV3-30在FL(9%)和tFL(13%)病例中也过度代表。总之,我们的结果表明抗原选择在FL发展中起作用,而IGHV3-48的使用可能有助于预测组织学转化。

 

原文链接:

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……